Abstract:Many intracellular proteins are reversibly modified by O-linked GlcNAc (O-GlcNAc), a post-translational modification that dynamically regulates fundamental cellular processes in response to diverse environmental cues. Accumulating evidence indicates that both excess and deficiency of protein O-GlcNAcylation can have deleterious effects on the cell, suggesting that maintenance of O-GlcNAc homeostasis is essential for proper cellular function. However, the mechanisms through which O-GlcNAc homeostasis is maintained in the physiologic state and altered in the disease state have not yet been investigated. Here, we demonstrate the existence of a homeostatic mechanism involving mutual regulation of the O-GlcNAc-cycling enzymes O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA) at the transcriptional level. Specifically, we found that OGA promotes Ogt transcription through cooperation with the histone acetyltransferase p300 and transcription factor CCAAT/enhancer-binding protein β (C/EBPβ). To examine the role of mutual regulation of OGT and OGA in the disease state, we analyzed gene expression data from human cancer data sets, which revealed that OGT and OGA expression levels are highly correlated in numerous human cancers, particularly in pancreatic adenocarcinoma. Using a KrasG12D -driven primary mouse pancreatic ductal adenocarcinoma (PDAC) cell line, we found that inhibition of extracellular signal-regulated kinase (ERK) signaling decreases OGA glycosidase activity and reduces OGT mRNA and protein levels, suggesting that ERK signaling may alter O-GlcNAc homeostasis in PDAC by modulating OGA-mediated Ogt transcription. Our study elucidates a transcriptional mechanism that regulates cellular O-GlcNAc homeostasis, which may lay a foundation for exploring O-GlcNAc signaling as a therapeutic target for human disease.

O-GlcNAcylation Increases PYGL Activity by Promoting Phosphorylation.

Phosphofructokinase 1 Glycosylation Regulates Cell Growth and Metabolism

Regulation of cancer metabolism by O-GlcNAcylation

O-GlcNAcylation regulates epidermal growth factor receptor intracellular trafficking and signaling

O-GlcNAcylation promotes tumor immune evasion by inhibiting PD-L1 lysosomal degradation

O-GlcNAcylation, a Sweet Link to the Pathology of Diseases

O-GlcNAcylation Promotes Pancreatic Tumor Growth by Regulating Malate Dehydrogenase 1

Regulation Of Glucose Homeostasis And Lipid Metabolism By Ppp1r3g-Mediated Hepatic Glycogenesis

O-GlcNAcylation of G6PD Promotes the Pentose Phosphate Pathway and Tumor Growth

O-GlcNAcylation Involvement in High Glucose-Induced Cardiac Hypertrophy Via ERK1/2 and Cyclin D2

O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth

O-GlcNAcylation of ATP-citrate lyase couples glucose supply to lipogenesis for rapid tumor cell proliferation

The essential role of YAP O-GlcNAcylation in high-glucose-stimulated liver tumorigenesis

O-GlcNAcylation of FBP1 Promotes Pancreatic Cancer Progression by Facilitating Its Lys48-linked Polyubiquitination in Hypoxic Environments

O-GlcNAcylation in cancer development and immunotherapy

O-GlcNAcase targets pyruvate kinase M2 to regulate tumor growth

Transcriptional Regulation of O-GlcNAc Homeostasis is Disrupted in Pancreatic Cancer

High Glucose Stimulates Proliferative Capacity of Liver Cancer Cells Possibly Via O‐GlcNAcylation‐dependent Transcriptional Regulation of GJC1

O-GlcNAcylation in tumorigenesis and its implications for cancer therapy

Glucose-mediated N-glycosylation of RPTPα Affects Its Subcellular Localization and Src Activation.

Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling